We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

174 hedge funds and large institutions have $1.44B invested in Cardiovascular Systems, Inc. in 2021 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 57 increasing their positions, 79 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% less funds holding

Funds holding: 183174 (-9)

11% less capital invested

Capital invested by funds: $1.62B → $1.44B (-$174M)

15% less call options, than puts

Call options by funds: $2.55M | Put options by funds: $3M

28% less repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 79

35% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 20

Holders
174
Holders Change
-9
Holders Change %
-4.92%
% of All Funds
3.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
57
Reduced
79
Closed
20
Calls
$2.55M
Puts
$3M
Net Calls
-$456K
Net Calls Change
-$1.16M

CSII Hedge Fund Activity: Q1 2021 in Review

174 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q1 2021, worth a combined $1.44B — down 11% from $1.62B a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of CSII and 13 opened new positions — a net loss of 7 holders — while 79 trimmed existing stakes and 57 added.

The largest buyer was RGM Capital, adding an estimated $19.1M. The largest seller was Renaissance Technologies, cutting an estimated $7.29M.

  • 174 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q1 2021, down from 183 in Q4 2020.
  • Funds reported $1.44B of Cardiovascular Systems, Inc. stock for Q1 2021, down 11% quarter-over-quarter.
  • 13 funds opened new Cardiovascular Systems, Inc. positions in Q1 2021 and 20 closed out, a net change of -7 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q1 2021 was RGM Capital, an estimated $19.1M added.
  • The largest Cardiovascular Systems, Inc. seller in Q1 2021 was Renaissance Technologies, an estimated $7.29M sold.

Based on aggregated 13F filings for Q1 2021.